+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Butorphanol Market by Route Of Administration, Application, End User, Distribution Channel - Global Forecast to 2030- Product Image
Butorphanol Market by Route Of Administration, Application, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Butorphanol Market by Route Of Administration, Application, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011533
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The butorphanol market is undergoing significant transformation, shaped by changing regulatory demands, advances in delivery technology, and shifting patient care models. Senior leaders need actionable insights to anticipate evolving market dynamics and position their organizations effectively.

Butorphanol Market Snapshot

The Butorphanol Market expanded from USD 283.74 million in 2024 to USD 296.11 million in 2025 and continues on a growth trajectory, projected to reach USD 364.90 million by 2030 with a CAGR of 4.28%. This growth reflects heightened demand for advanced analgesia, a rising focus on opioid safety, and increased adoption of non-invasive therapies. Evolving clinical practices and policy changes further support strategic investments and product innovation across the sector.

Scope & Segmentation

This report delivers a comprehensive view, assessing core segments, market regions, and pivotal technologies influencing the butorphanol landscape.

  • Route of Administration: Injection (comprising intramuscular and intravenous forms), Nasal Spray, and Tablet options are tracked for relevance across care settings.
  • Clinical Application: Focus on Chronic Pain Management, Labor Pain Management, and Surgical Pain Management reflects demand for versatile analgesic solutions in varied patient populations.
  • End User: Analysis spans Ambulatory Care Centers, Home Healthcare, and Hospitals, capturing shifts in care delivery and decentralized health models.
  • Distribution Channel: Highlights include Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy, each supporting distinct procurement and dispensing workflows.
  • Regional Coverage: Americas (United States [California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio], Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Market Participants: Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Pfizer Inc., Mylan N.V., Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Sagent Pharmaceuticals, Inc., Baxter International Inc., B. Braun Melsungen AG, Apotex Inc.

Key Takeaways for Senior Decision Makers

  • The market is swiftly adapting to regulatory scrutiny by advancing safer opioid formulations and enhancing monitoring protocols.
  • Patient-centric delivery, especially via intranasal and sustained-release systems, is expanding adoption in outpatient and home environments.
  • Collaboration across the pharmaceutical, digital health, and device sectors is accelerating development of integrated analgesia solutions tailored for diverse care settings.
  • Resilient, diversified supply chains and local manufacturing investments are becoming crucial as companies prepare for future policy and trade disruptions.
  • Strategic pricing and regional production initiatives support competitive positioning amid varied healthcare reimbursement landscapes, particularly in high-growth emerging economies.
  • Personalized pain management, leveraging genetic profiling and continuous patient feedback, is increasingly relevant for differentiation and patient outcomes across clinical segments.

Tariff Impact: The 2025 US Ripple Effect

Recent tariff measures in the US have raised costs for imported pharmaceutical ingredients and packaging, prompting manufacturers to shift sourcing strategies. Nearshoring and optimizing formulation techniques are underway to stabilize costs and reduce exposure to trade volatility. These changes are also influencing price negotiations throughout the distribution network, encouraging adoption of value-based contracts that tie reimbursement to therapeutic outcomes.

Methodology & Data Sources

This report integrates comprehensive secondary research with targeted primary interviews across key regions. Analysts utilized regulatory documents, scientific publications, import-export statistics, and financial disclosures, complemented by discussions with industry executives and policy experts. Triangulation and independent peer review ensure data accuracy and consistent segmentation across all examined categories.

Butorphanol Market: Why This Report Matters

  • Enables senior leaders to anticipate technological, regulatory, and commercial trends, supporting more informed strategic planning.
  • Identifies actionable growth opportunities by analyzing market segments, end-user preferences, and region-specific drivers.
  • Guides investment decisions by illustrating how supply chain, tariff policy, and patient-led care dynamics interact within the evolving opioid analgesics landscape.

Conclusion

The butorphanol market is entering a phase of dynamic evolution as new policies, innovative technologies, and changing patient expectations drive segment expansion. Organizations equipped with timely, segmented intelligence can better navigate market complexities and capitalize on long-term opportunities in pain management.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Butorphanol Market, by Route Of Administration
8.1. Introduction
8.2. Injection
8.2.1. Intramuscular Injection
8.2.2. Intravenous Injection
8.3. Nasal Spray
8.4. Tablet
9. Butorphanol Market, by Application
9.1. Introduction
9.2. Chronic Pain Management
9.3. Labor Pain Management
9.4. Surgical Pain Management
10. Butorphanol Market, by End User
10.1. Introduction
10.2. Ambulatory Care Center
10.3. Home Healthcare
10.4. Hospital
11. Butorphanol Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Americas Butorphanol Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Butorphanol Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Butorphanol Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Teva Pharmaceutical Industries Ltd.
15.3.2. Sandoz International GmbH
15.3.3. Pfizer Inc.
15.3.4. Mylan N.V.
15.3.5. Fresenius Kabi AG
15.3.6. Hikma Pharmaceuticals PLC
15.3.7. Sagent Pharmaceuticals, Inc.
15.3.8. Baxter International Inc.
15.3.9. B. Braun Melsungen AG
15.3.10. Apotex Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BUTORPHANOL MARKET MULTI-CURRENCY
FIGURE 2. BUTORPHANOL MARKET MULTI-LANGUAGE
FIGURE 3. BUTORPHANOL MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BUTORPHANOL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BUTORPHANOL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BUTORPHANOL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BUTORPHANOL MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BUTORPHANOL MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BUTORPHANOL MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BUTORPHANOL MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BUTORPHANOL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BUTORPHANOL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BUTORPHANOL MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BUTORPHANOL MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BUTORPHANOL MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BUTORPHANOL MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BUTORPHANOL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BUTORPHANOL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BUTORPHANOL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BUTORPHANOL MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BUTORPHANOL MARKET SIZE, BY INTRAMUSCULAR INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BUTORPHANOL MARKET SIZE, BY INTRAVENOUS INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BUTORPHANOL MARKET SIZE, BY NASAL SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BUTORPHANOL MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BUTORPHANOL MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BUTORPHANOL MARKET SIZE, BY LABOR PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BUTORPHANOL MARKET SIZE, BY SURGICAL PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BUTORPHANOL MARKET SIZE, BY AMBULATORY CARE CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BUTORPHANOL MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BUTORPHANOL MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BUTORPHANOL MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BUTORPHANOL MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BUTORPHANOL MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES BUTORPHANOL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. CANADA BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 38. CANADA BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 39. CANADA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. CANADA BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. CANADA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. MEXICO BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 43. MEXICO BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 44. MEXICO BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. MEXICO BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. MEXICO BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. UNITED KINGDOM BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. UNITED KINGDOM BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 65. UNITED KINGDOM BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. UNITED KINGDOM BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. UNITED KINGDOM BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. GERMANY BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 69. GERMANY BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 70. GERMANY BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. GERMANY BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. GERMANY BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. FRANCE BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 74. FRANCE BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 75. FRANCE BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. FRANCE BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. FRANCE BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. RUSSIA BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 79. RUSSIA BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. ITALY BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. ITALY BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 85. ITALY BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. ITALY BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. ITALY BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. SPAIN BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 89. SPAIN BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 90. SPAIN BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. SPAIN BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. SPAIN BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. UNITED ARAB EMIRATES BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. SAUDI ARABIA BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 99. SAUDI ARABIA BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 100. SAUDI ARABIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. SAUDI ARABIA BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. SAUDI ARABIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. SOUTH AFRICA BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 104. SOUTH AFRICA BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 105. SOUTH AFRICA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. SOUTH AFRICA BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. SOUTH AFRICA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. DENMARK BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 109. DENMARK BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 110. DENMARK BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. DENMARK BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. DENMARK BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. NETHERLANDS BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 114. NETHERLANDS BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 115. NETHERLANDS BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. NETHERLANDS BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. NETHERLANDS BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. QATAR BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 119. QATAR BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 120. QATAR BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. QATAR BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. QATAR BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. FINLAND BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 124. FINLAND BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 125. FINLAND BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. FINLAND BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. FINLAND BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. NIGERIA BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 134. NIGERIA BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. EGYPT BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 139. EGYPT BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 140. EGYPT BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. EGYPT BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. EGYPT BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. TURKEY BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 144. TURKEY BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 145. TURKEY BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. TURKEY BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. TURKEY BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. ISRAEL BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 149. ISRAEL BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 150. ISRAEL BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. ISRAEL BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. NORWAY BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 154. NORWAY BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 155. NORWAY BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. NORWAY BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. NORWAY BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. POLAND BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 159. POLAND BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 160. POLAND BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. POLAND BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. POLAND BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. SWITZERLAND BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 164. SWITZERLAND BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 165. SWITZERLAND BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SWITZERLAND BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. SWITZERLAND BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 174. CHINA BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 175. CHINA BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 176. CHINA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. CHINA BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. CHINA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. INDIA BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 180. INDIA BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 181. INDIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. INDIA BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. INDIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. JAPAN BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 185. JAPAN BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 186. JAPAN BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. JAPAN BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. JAPAN BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. SOUTH KOREA BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. THAILAND BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 205. THAILAND BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 206. THAILAND BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. THAILAND BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. THAILAND BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. PHILIPPINES BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 210. PHILIPPINES BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 211. PHILIPPINES BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. PHILIPPINES BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. PHILIPPINES BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. SINGAPORE BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 220. SINGAPORE BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 221. SINGAPORE BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. SINGAPORE BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. SINGAPORE BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. VIETNAM BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 225. VIETNAM BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. TAIWAN BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 230. TAIWAN BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN BUTORPHANOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. BUTORPHANOL MARKET SHARE, BY KEY PLAYER, 2024
TABLE 235. BUTORPHANOL MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Butorphanol market report include:
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Pfizer Inc.
  • Mylan N.V.
  • Fresenius Kabi AG
  • Hikma Pharmaceuticals PLC
  • Sagent Pharmaceuticals, Inc.
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Apotex Inc.

Table Information

Report AttributeDetails
No. of Pages181
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 296.11 Million
Forecasted Market Value ( USD ) by 2030 $ 364.9 Million
Compound Annual Growth Rate4.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Butorphanol Tartrate Injection Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Butorphanol Tartrate Injection Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 80 Pages
  • Global
From
Butorphanol (CAS 42408-82-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Butorphanol (CAS 42408-82-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Plumb's Veterinary Drug Handbook. Edition No. 10 - Product Image

Plumb's Veterinary Drug Handbook. Edition No. 10

  • Book
  • 1568 Pages
Clonidine Market by Product Form, Indication, Distribution Channel, End User, Route of Administration, Dosage Strength - Global Forecast to 2030 - Product Image

Clonidine Market by Product Form, Indication, Distribution Channel, End User, Route of Administration, Dosage Strength - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
Desmopressin Market by End User, Indication, Product Type, Route of Administration, Distribution Channel - Global Forecast to 2030 - Product Image

Desmopressin Market by End User, Indication, Product Type, Route of Administration, Distribution Channel - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From

About the Butorphanol Market

Butorphanol is an analgesic drug used to treat moderate to severe pain. It is a synthetic opioid agonist-antagonist, meaning it has both agonist and antagonist properties. It is a Schedule IV controlled substance in the United States, meaning it has a low potential for abuse and dependence. Butorphanol is available in both intranasal and injectable forms, and is commonly used in the treatment of migraine headaches, postoperative pain, and labor pain. It is also used to treat opioid withdrawal symptoms. Butorphanol is generally considered to be a safe and effective analgesic, with few side effects. Common side effects include nausea, dizziness, and drowsiness. It is important to note that butorphanol should not be used in combination with other opioids, as this can increase the risk of serious side effects. Some companies in the butorphanol market include Endo Pharmaceuticals, Mylan Pharmaceuticals, and Teva Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.